Preventative healthcare company, Neko Health, has launched a second site in London and plans to open two more sites in the capital and expand to other UK cities this year.

Offered by a Swedish company – which is co-founded by Spotify founder, Daniel Ek – Neko Health involves a 10-minute body scan that collects 50 million data points to assess health and detect early markers for disease. It checks moles and marks across the body, symptoms of metabolic syndrome and risk factors for stroke and heart attack, along with blood sugar levels to assess pre-diabetes risk.

Individuals receive full results immediately after the scan, as part of a doctor-led consultation. The whole experience is complete in just under an hour and costs £299. Eighty per cent of users book and pre-pay for the following year.

The first UK site opened in London’s Marylebone in September. More than 15,000 scans have now been completed across the two existing sites, in Stockholm and London. The scanner has undergone continuous development: improvements include 50 per cent more images at a 60 per cent higher resolution. Results are also now benchmarked against age-group peers for better comparison.

The new architecturally-striking, standalone site in Spitalfields will have the capacity to serve up to 30,000 people annually.

CEO and co-founder, Hjalmar Nilsonne, says: "This Health Centre is built for scale, and we’re doubling down in London. Healthcare has long been centred around reactiveness, with care often beginning only after symptoms appear. At Neko Health, we turn that notion on its head – our spaces celebrate preventive health, making wellbeing something to be seen, embraced and experienced.”

After a year of operation, scanning around 2,700 people, 1 per cent received a potentially life-saving intervention despite being unaware of pre-existing conditions. Twenty eight per cent who were diagnosed with significant conditions were under the age of 50; 6.6 per cent of the people scanned had a moderate to severe health condition – including skin cancer, Type 2 diabetes and cardiovascular disease – and 90 per cent were not aware of a serious health condition or had any symptoms prior to the visit.